Skip to main content
. 2017 Jun 23;38:81–88. doi: 10.1007/8904_2017_29

Table 1.

Demographics and baseline characteristics (safety set)

<2 years (N = 2) 2 to <12 years (N = 5) 12 to <18 years (N = 5) ≥18 years (N = 6) All (N = 18)
Age (years)
 Mean (SD) 1.5 (0.2) 7.7 (2.4) 13.9 (1.2) 21.1 (2.3) 13.2 (7.1)
 Min, max 1.3, 1.6 5.0, 11.0 13.0, 15.4 19.0, 24.0 1.3, 24.0
Sex
 Male 2 (100.0%) 4 (80.0%) 2 (40.0%) 1 (16.7%) 9 (50.0%)
 Female 0 1 (20.0%) 3 (60.0%) 5 (83.3%) 9 (50.0%)
Age at HT-1 diagnosis (months)
 Mean (SD) 8.0 (2.1) 8.2 (6.4) 7.0 (4.1) 8.8 (5.3) 8.1 (4.8)
Age at nitisinone treatment start (months)
 Mean (SD) 8.5 (2.1) 8.2 (6.4) 7.2 (4.3) 15.3 (14.3) 10.3 (9.4)

SD standard deviation